<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2025-472
Date of Submission: 2025-02-20

This report was submitted by a Patient from Molina-Harris Medical Center concerning patient ANON-PX-3069. The subject is an adult female with a significant medical history including hypertension, type 2 diabetes, coronary artery disease, seasonal allergies. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Amoxicillin administered via the Intravenous route at a dosage of 464mg, initiated on 2024-11-23 for Bacterial infection with the course ongoing.

On approximately 2025-01-11, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Maculopapular Rash, Dizziness, Hepatotoxicity. The Maculopapular Rash was classified as Life-threatening in severity. This necessitated clinical intervention. The documented action was: Prescribed enjoy and advised rate. The current patient status regarding this symptom is 'Unknown'. The Dizziness was classified as Life-threatening in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Not Recovered'. The Hepatotoxicity was classified as Moderate in severity. This necessitated clinical intervention. The current patient status regarding this symptom is 'Not Recovered'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. A Naranjo score of 4 was calculated, The assessment concluded the relationship was 'Possible'. Dechallenge/Rechallenge status was noted as: 'Not applicable'. The on-site pharmacist concurred with the assessment during a routine case review. 

Reporter's Narrative Summary: Job prove local be side tough.</data>
report_id: ADR-2025-472
report_date: '2025-02-20'
patient_details:
  patient_id: ANON-PX-3069
  gender: Female
  relevant_history:
  - hypertension
  - type 2 diabetes
  - coronary artery disease
  - seasonal allergies
suspected_drugs:
- drug_name: Amoxicillin
  dosage: 464mg
  route_of_administration: Intravenous
  start_date: '2024-11-23'
  indication_for_use: Bacterial infection
adverse_reactions:
- symptom_name: Maculopapular Rash
  onset_date: '2025-01-11'
  severity: Life-threatening
  outcome: Unknown
  intervention_required: true
  intervention_details: Prescribed enjoy and advised rate.
- symptom_name: Dizziness
  onset_date: '2025-01-11'
  severity: Life-threatening
  outcome: Not Recovered
  intervention_required: false
- symptom_name: Hepatotoxicity
  onset_date: '2025-01-11'
  severity: Moderate
  outcome: Not Recovered
  intervention_required: true
causality_assessment:
  assessment_conclusion: Possible
  dechallenge_rechallenge: Not applicable
  naranjo_score: 4
reporting_facility: Molina-Harris Medical Center
reporter_type: Patient
notes: Job prove local be side tough.
